Differentiating benign from malignant cardiac tumors with cardiac magnetic resonance imaging

The purpose of this analysis is to describe the differences in cardiac magnetic resonance characteristics between benign and malignant tumors, which would be helpful for surgical planning. This was a prospective cohort study of 130 patients who underwent cardiac magnetic resonance imaging for evalua...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of thoracic and cardiovascular surgery 2019-05, Vol.157 (5), p.1912-1922.e2
Main Authors: Kassi, Mahwash, Polsani, Venkateshwar, Schutt, Robert C., Wong, Solomon, Nabi, Faisal, Reardon, Michael J., Shah, Dipan J.
Format: Article
Language:English
Subjects:
Adult
Aged
Algorithms
cardiac magnetic resonance imaging
cardiac tumors
Contrast Media - administration & dosage
Decision Support Techniques
Decision Trees
Diagnosis, Differential
Female
first-pass perfusion
Gadolinium DTPA - administration & dosage
Georgia
Heart Neoplasms - diagnostic imaging
Heart Neoplasms - pathology
Humans
Magnetic Resonance Imaging, Cine
Male
Middle Aged
Neoplasm Invasiveness
Perfusion Imaging - methods
Predictive Value of Tests
Prospective Studies
Reproducibility of Results
Texas
Tumor Burden
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The purpose of this analysis is to describe the differences in cardiac magnetic resonance characteristics between benign and malignant tumors, which would be helpful for surgical planning. This was a prospective cohort study of 130 patients who underwent cardiac magnetic resonance imaging for evaluation of a suspected cardiac mass. After excluding thrombi and tumors without definitive diagnosis, 66 tumors were evaluated for morphologic features and tissue composition. Of the 66 patients, 39 (59.0%) had malignant tumors and 27 (41.0%) had benign tumors. Patients with malignant tumors were younger when compared with those with benign tumors (age 51 years [42.8-60.0] vs 65 years [60.0-71.0] median). Malignant tumors more often demonstrated tumor invasion (69% vs 0% P 
ISSN:0022-5223
1097-685X
DOI:10.1016/j.jtcvs.2018.09.057